Andrea Eshelman
Psychiatric/Mental Health · East Liverpool, OHNPI 1689829137
Payments from drug & device makers
Across 212 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$649
- AbbVie$620
- Axsome Therapeutics, Inc.$481
- Corium, LLC$374
- Otsuka America Pharmaceutical, Inc.$242
- Takeda Pharmaceuticals U.S.A., Inc.$213
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,84998%
- Education$742%
- Other$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$130
How this compares
$3,944 in reported general payments places this provider in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 74 | $109,777 |
| RexultiBrexpiprazole | 45 | $75,801 |
| TrintellixVortioxetine Hydrobromide | 88 | $46,932 |
| Invega SustennaPaliperidone Palmitate | 20 | $45,973 |
| CaplytaLumateperone Tosylate | 21 | $33,220 |
| FetzimaLevomilnacipran Hcl | 23 | $15,382 |
| AuvelityDextromethorphan Hbr/Bupropion | 11 | $12,023 |
| Lurasidone Hcl | 39 | $10,375 |
| Paliperidone ErPaliperidone | 41 | $7,080 |
| Aripiprazole | 73 | $6,369 |
| Buspirone Hcl | 299 | $3,919 |
| Lisdexamfetamine Dimesylate | 15 | $3,216 |
| Vilazodone Hcl | 22 | $3,058 |
| Quetiapine Fumarate | 164 | $2,922 |
| Ziprasidone Hcl | 69 | $2,724 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Fetzima | $620 | $125,16097 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $242 | $75,80145 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $213 | $46,93288 claims |
| Johnson & JohnsonInvega Sustenna | $121 | $45,97320 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $649 | $33,22021 claims |
| Axsome Therapeutics, Inc.Auvelity | $481 | $12,02311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.
Other psychiatric/mental health in East Liverpool
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Terri PopovitzCincinnati$161K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
- Rachael McLaughlinMaple Heights$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.